Clinical Rheumatology

, Volume 17, Issue 4, pp 288–292

Study of pro-inflammatory (TNF-α, IL-1α, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: Correlations with clinical and laboratory parameters

  • N. Kutukculer
  • S. Caglayan
  • F. Aydogdu
Original Article


Acute phase proteins, synovial fluid (SF) cellular infiltrates, pro-inflammatory (TNF-α, IL-1α, IL-6) and Th1 (IL-2) and Th2 (IL-4) derived cytokine levels both in plasma and SF were examined in pauciarticular and polyarticular juvenile chronic arthritis (JCA) patients during the active (n=22) and inactive (n=14) period in order to determine pathogenic mechanisms and correlations between cytokines and laboratory parameters showing disease activity. The erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) and IgG concentrations were found to be significantly elevated in the active period of JCA. In pauciarticular JCA patients, when compared with their peripheral blood lymphocyte subpopulations, SF CD3+ cells (73.1%) and HLA-DR+ active T cells (22.5%) were found to be significantly increased. In the active period of JCA, plasma TNF-α and IL-6 concentrations were significantly elevated. Plasma IL-2 and IL-4 levels were not elevated and were found to be similar to those in the inactive phase and in healthy controls. SF IL-6, TNF-α and IL-1α levels were extremely high in all the patients. SF IL-4 and IL-2 levels were all undetectable. There was a significant correlation between ESR values and plasma IL-6 levels and between serum CRP levels and plasma IL-6 and TNF-α concentrations. In conclusion, increased local production of pro-inflammatory cytokines appears to account for the articular manifestations of JCA. The impaired production of anti-inflammatory Th2-derived cytokines (IL-4) seems to cause increased production of inflammatory cytokines acting on the balance between them. The deficit in IL-2 production was not suggested to be primarily involved in the pathogenesis. In addition, not only CRP and ESR values, but also plasma IL-6 and TNF-α concentrations may be used as markers of disease activity.


Acute phase response Interleukins 1α, 2, 4, and 6 Juvenile chronic arthritis Tumour necrosis factor α 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brewer EJ, Bass JC, Baum J, et al. Current proposed revision of JRA criteria. Arthritis Rheum 1977;20:195–8.PubMedGoogle Scholar
  2. 2.
    Wood PHN. Special meeting on nomenclature and classification of arthritis in children. In: Munther M, editor. The care of rheumatic children. Basel: EULAR, 1978.Google Scholar
  3. 3.
    Rooney M, David J, Symons J, Di Giovine F, Varsani H, Woo P. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995;34:454–60.PubMedGoogle Scholar
  4. 4.
    Schaller JG. Juvenile rheumatoid arthritis. In Behrman RE, Kliegmon RM, Nelson WE, Vaughan VC, editors. Nelson textbook of pediatrics, 14th edn. Philadelphia: WB Saunders, 1992:612–21.Google Scholar
  5. 5.
    Fye KH, Sack KH. Rheumatic Diseases. In: Stites DP, Terr AL, editors, 7th ed. Basic and Clinical Immunology. London: Appleton & Lange, 1991:438–64.Google Scholar
  6. 6.
    Emery P, Luqmani R. The validity of surrogate markers in rheumatic disease. Br J Rheumatol 1993;32(suppl 3):3–8.Google Scholar
  7. 7.
    Lepore L, Pennesi M, Saletta S, Perticarari S, Presani G, Prodan M. Study of IL-2, IL-6, TNF-alpha, IFN-gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol 1994;12:561–5.PubMedGoogle Scholar
  8. 8.
    Spadaro A, Riccieri V, Sili Scavalli A, Sensi F, Fiore D, Taccari E, Zoppini A. Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters. Rev Rhum Engl Ed 1996;63:171–7.PubMedGoogle Scholar
  9. 9.
    Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumor necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Rheumatol 1989;75:306–10.Google Scholar
  10. 10.
    Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebman P, Kaulfersch W, et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995;38:211–20.PubMedGoogle Scholar
  11. 11.
    De Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A. Serum interleukin levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol 1992;10:493–8.PubMedGoogle Scholar
  12. 12.
    Hermann E, Fleischer B, Mayet WJ, Poralla T. Correlation of synovial fluid interleukin-6 (IL-6) activities with IgG concentrations in patients with inflammatory joint diseases and osteoarthritis. Clin Exp Rheumatol 1989;7:411–4.PubMedGoogle Scholar
  13. 13.
    Eberhard BA, Laxer RM, Andersson U, Silverman ED. Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol 1994;96:260–6.PubMedGoogle Scholar
  14. 14.
    Miuller K, Hansen MB, Zak M, Nielsen S, Pedersen FK, de Nully P, Bendtzen K. Autoantibodies to IL-1a in sera from umblical cords, children and adults and from patients with juvenile chronic arthritis. Scand J Rheumatol 1996;25:64–7.Google Scholar
  15. 15.
    De Benedetti F, Pignatti P, Massa M, Sartirana P, Ravelli A, Martini A. Circulating levels of interleukin-1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis. Clin Exp Rheumatol 1995;13:779–84.PubMedGoogle Scholar
  16. 16.
    Venables P. Rheumatoid arthritis and other joint diseases. In: Brostoff J, Scadding GK, Male D, Roitt IM, editors. 1st ed. Clinical Immunology, Hong Kong, Gower Medical, 1991;5.1–5.15.Google Scholar
  17. 17.
    Forre O, Dobloug JH, Natvig JB. Augmented numbers of HLA-DR positive T lymphocytes in the synovial fluid and synovial tissues of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Scand J Immunol 1993;38:75–82.PubMedGoogle Scholar
  18. 18.
    Afeltra A, Galeazzi M, Ferri GM, Amoroso A, De Pita O, Porzio F, Bonomo L. Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann Rheum Dis 1993;52:457–60.PubMedGoogle Scholar
  19. 19.
    Miossec P. Pro- and antiinflammatory cytokine balance in rheumatoid arthritis. Clin Exp Rheumatol 1995;13(suppl 12):S13–S16.Google Scholar
  20. 20.
    Miossec P, Chomarat P, Dechanet J, Moreau JF, Roux JP, Delmas P, Banchereau J. Interleukin-4 inhibits ex vivo production of proinflammatory cytokines and immunoglobulins by rheumatoid synovitis. Arthritis Rheum 1992;35:874–83.PubMedGoogle Scholar
  21. 21.
    Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P. The balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995;154:1432–9.PubMedGoogle Scholar
  22. 22.
    Lipnick RN, Tsokos GC, Magilavy DB. Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis. Rheum Dis Clin North Am 1991;7:843–59.Google Scholar
  23. 23.
    Zvaifler NJ. Current concepts of pathogenesis of joint destruction in rheumatoid arthritis. Rheumatology in Europe 1995;suppl 2:151–67.Google Scholar

Copyright information

© Clinical Rheumatology 1998

Authors and Affiliations

  • N. Kutukculer
    • 1
  • S. Caglayan
    • 1
  • F. Aydogdu
    • 1
  1. 1.Department of Pediatrics, The Medical SchoolEge UniversityIzmirTurkey
  2. 2.Department of Pediatrics, Faculty of MedicineEge UniversityBornova-IzmirTurkey

Personalised recommendations